BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18021809)

  • 21. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion.
    Nevo Y; Soffer D; Kutai M; Zelnik N; Saada A; Jossiphov J; Messer G; Shaag A; Shahar E; Harel S; Elpeleg O
    J Child Neurol; 2002 Jul; 17(7):499-504. PubMed ID: 12269728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New mutations in TK2 gene associated with mitochondrial DNA depletion.
    Galbiati S; Bordoni A; Papadimitriou D; Toscano A; Rodolico C; Katsarou E; Sciacco M; Garufi A; Prelle A; Aguennouz M'; Bonsignore M; Crimi M; Martinuzzi A; Bresolin N; Papadimitriou A; Comi GP
    Pediatr Neurol; 2006 Mar; 34(3):177-85. PubMed ID: 16504786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter- and/or intra-organ distribution of mitochondrial C3303T or A3243G mutation in mitochondrial cytopathy.
    Iwanaga R; Koga Y; Aramaki S; Kato S; Kato H
    Acta Neuropathol; 2001 Feb; 101(2):179-84. PubMed ID: 11271374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells.
    Paredes JA; Zhou X; Höglund S; Karlsson A
    PLoS One; 2013; 8(1):e53698. PubMed ID: 23341978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical heterogeneity associated with mitochondrial DNA depletion in muscle.
    Campos Y; Martín MA; García-Silva T; del Hoyo P; Rubio JC; Castro-Gago M; García-Peñas J; Casas J; Cabello A; Ricoy JR; Arenas J
    Neuromuscul Disord; 1998 Dec; 8(8):568-73. PubMed ID: 10093063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of myopathy with large-scale mitochondrial DNA duplications and deletions: which is pathogenic?
    Manfredi G; Vu T; Bonilla E; Schon EA; DiMauro S; Arnaudo E; Zhang L; Rowland LP; Hirano M
    Ann Neurol; 1997 Aug; 42(2):180-8. PubMed ID: 9266727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
    Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
    Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic biochemical characterization of cytosolic enzymes in thymidine nucleotide synthesis in adult rat tissues: implications for tissue specific mitochondrial DNA depletion and deoxynucleoside-based therapy for TK2-deficiency.
    Wang L; Sun R; Eriksson S
    BMC Mol Cell Biol; 2020 Apr; 21(1):33. PubMed ID: 32345222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular syndrome associated with the 3291T-->C mutation of mitochondrial DNA: a second case.
    Uziel G; Carrara F; Granata T; Lamantea E; Mora M; Zeviani M
    Neuromuscul Disord; 2000 Aug; 10(6):415-8. PubMed ID: 10899447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation.
    Dorado B; Area E; Akman HO; Hirano M
    Hum Mol Genet; 2011 Jan; 20(1):155-64. PubMed ID: 20940150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
    Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
    EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intragenic inversion of mtDNA: a new type of pathogenic mutation in a patient with mitochondrial myopathy.
    Musumeci O; Andreu AL; Shanske S; Bresolin N; Comi GP; Rothstein R; Schon EA; DiMauro S
    Am J Hum Genet; 2000 Jun; 66(6):1900-4. PubMed ID: 10775530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial myopathy mimicking fibromyalgia syndrome.
    Villanova M; Selvi E; Malandrini A; Casali C; Santorelli FM; De Stefano R; Marcolongo R
    Muscle Nerve; 1999 Feb; 22(2):289-91. PubMed ID: 10024147
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency.
    Saada A; Ben-Shalom E; Zyslin R; Miller C; Mandel H; Elpeleg O
    Biochem Biophys Res Commun; 2003 Oct; 310(3):963-6. PubMed ID: 14550298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation.
    Zhou X; Kannisto K; Curbo S; von Döbeln U; Hultenby K; Isetun S; Gåfvels M; Karlsson A
    PLoS One; 2013; 8(3):e58843. PubMed ID: 23505564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
    Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
    Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres.
    Chinnery PF; Howel D; Turnbull DM; Johnson MA
    J Neurol Sci; 2003 Jul; 211(1-2):63-6. PubMed ID: 12767499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion.
    Tulinius M; Moslemi AR; Darin N; Holme E; Oldfors A
    Neuromuscul Disord; 2005 Jun; 15(6):412-5. PubMed ID: 15907288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
    Lalani SR; Vladutiu GD; Plunkett K; Lotze TE; Adesina AM; Scaglia F
    Arch Neurol; 2005 Feb; 62(2):317-20. PubMed ID: 15710863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological Features in Paediatric Patients with TK2 Deficiency.
    Jou C; Nascimento A; Codina A; Montoya J; López-Gallardo E; Emperador S; Ruiz-Pesini E; Montero R; Natera-de Benito D; Ortez CI; Marquez J; Zelaya MV; Gutierrez-Mata A; Badosa C; Carrera-García L; Expósito-Escudero J; Roldán M; Camara Y; Marti R; Ferrer I; Jimenez-Mallebrera C; Artuch R
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.